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Abstract Polyamine incorporation or cross-linking of proteins,
post-translational modi¢cations mediated by transglutaminase 2
(TGase 2), have been implicated in a variety of physiological
functions including cell adhesion, extracellular matrix formation
and apoptosis. To better understand the intracellular regulation
mechanism of TGase 2, the properties of biotinylated poly-
amines as substrates for determining in situ TGase activity
were analyzed. We synthesized biotinylated spermine (BS),
and compared the in vitro and in situ incorporation of BS
with that of biotinylated pentylamine (BP), which is an arti¢cial
polyamine derivative. When measured in vitro, BP showed a
signi¢cantly higher incorporation rate than BS. In contrast, in
situ incorporation of both BS and BP was not detected even in
TGase 2-overexpressed 293 cells. Cells exposed to high calcium
showed a marked increase of BP incorporation but not of BS.
These data indicate that the in situ activity of TGase 2 gives
di¡erent results with di¡erent substrates, and suggest the possi-
bility of overrepresentation of in situ TGase 2 activity when
assayed with BP. Therefore, careful interpretation or evaluation
of in situ TGase 2 activity may be required.
- 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Transglutaminase 2 (TGase 2, or tissue TGase) is a calci-
um-dependent enzyme that catalyzes polyamine conjugation
or cross-linking of proteins through the transamidation reac-
tion between the Q-carboxyamide group of a glutamine residue
in a polypeptide chain and the primary amine group of a
polyamine or a lysine residue in a polypeptide chain [1]. Of
eight isoforms of TGase, which share a common amino acid
sequence at the active site (GQCWV) and a strict calcium
dependence for their transamidation activity [2], TGase 2 is
characterized by ubiquitous tissue distribution, cytosol and
nuclear localization [3], and by exhibiting GTP binding and
hydrolysis activity [4]. Although TGase 2 null mice showed no
distinct phenotype [5], TGase 2 has been implicated in a wide
variety of physiological functions including cell adhesion [6],
formation of extracellular matrix [7] and apoptosis [8]. Re-
cently, much attention has focused on the role of proteins
modi¢ed by TGase 2 in various diseases. For instance, de-
amidated gluten is implicated in celiac disease [9], and poly-
amine-conjugated tau and cross-linked mutant huntingtin
have also been thought to contribute to the pathological pro-
gression of Alzheimer’s disease and Huntington’s disease, re-
spectively [10,11]. However, the precise molecular mecha-
nism(s) involved in activation of TGase 2 are not fully
understood.
The transamidation activity of TGase 2 is regulated by
calcium and GTP [12]. Previous studies showed that the in-
creased expression level of TGase 2 by retinoic acid is not
correlated with its increase of in situ activity [13], suggesting
that TGase 2 activity is tightly regulated in the intracellular
milieu, and derangement of the regulation mechanism is likely
involved in the disease processes. Elucidation of the intracel-
lular regulation mechanisms requires the accurate measure-
ment of protein^polyamine conjugates resulting from in situ
activity of TGase 2. The determination of [14C]putrescine in-
corporated into N,NP-dimethylcasein has been used for assays
of in vitro TGase 2 activity [14]. However, the application of
this classical method for assaying in situ activity is limited by
the need for extensive proteolysis and subsequent HPLC anal-
ysis [15]. Recently, a £uorescent amine or biotinylated amine
has been used as an alternative acyl acceptor substrate for the
rapid and sensitive measurement of in situ activity of TGase 2
[16]. In contrast to in vitro assays which use N,NP-dimethyl-
casein as a acyl donor, the in situ assay relies on unknown
intracellular proteins for conjugation of intracellular poly-
amines. Moreover, in situ TGase 2 activity could be a¡ected
by the intracellular concentration of endogenous polyamines,
such as putrescine, spermidine, and spermine, which re£ect
their metabolic status.
Biotinylated pentylamine (BP) is commonly used as a bio-
tinylated amine for the measurement of in situ activity of
TGase. However, BP is not involved in the biosynthesis of
spermidine and spermine by S-adenosylmethionine decarbox-
ylase or degraded by polyamine oxidase because pentylamine,
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a structural analog of putrescine, is an arti¢cial substrate.
Therefore, there is a possibility of the introduction of a bias
in the representation of the physiological polyamine conjuga-
tion by in situ TGase activity when assayed with BP. In this
report, we synthesized biotinylated spermine (BS), a derivative
of natural polyamine, and compared the conjugation of BP
and BS into cellular proteins by TGase 2 in order to assess the
validity and e⁄cacy of in situ TGase 2 activity assayed with
BP.
2. Materials and methods
2.1. Synthesis of biotinylated spermine
The principal details of biotinylated spermine synthesis are illus-
trated in Fig. 1. A solution of ethyl tri£uoroacetate (TFA, 0.59 ml,
4.94 mmol) in tetrahydrofuran (THF, 5 ml) was added dropwise for
5 min to a solution of spermine 1 (0.5 g, 2.47 mmol) in THF (30 ml)
at 0‡C. The reaction was monitored by thin layer chromatography
(TLC) (solvent A) and, upon completion (approx. 10 min), the mix-
ture was concentrated in vacuo to a¡ord the crude product. N,N-di-
TFA spermine 2 was obtained as a white crystal by recrystallization
with MeOH/EtOAc. For amidation, N,N-di-TFA spermine 2 (0.32 g,
0.82 mmol), biotin (0.20 g, 0.82 mmol), 1,3-dicyclohexylcarbodiimide
(DCC, 0.25 g, 1.23 mmol) and 1-hydroxybenzotriazole (HOBt, 0.02 g,
0.16 mmol) were added to the 30 ml portion of anhydrous dimethyl-
formamide (DMF) into a £ame-dried round bottom £ask. The reac-
tion was stirred for 24 h at room temperature and extracted with 20%
MeOH/CH2Cl2. The organic mixture was washed with brine (2U30
ml), dried over Na2SO4 and concentrated under reduced pressure. The
pure product 3 was obtained as a syrup by column chromatography
with solvent B. Deprotection of compound 3 (0.20 g, 0.32 mmol) was
performed with 2 M NH3/MeOH (20 ml). The reaction was main-
tained at room temperature with vigorous stirring, until TLC exami-
nation showed total conversion into the lower moving product 4 (Rf
0.43, solvent C). The solvent was removed under reduced pressure.
The crude mixture was dissolved in THF and 1 M ethereal HCl was
added slowly with stirring. The white solid which was formed by
adding ethereal HCl was ¢ltered and washed with diethyl ether
(3U30 ml). N1-(4-Aminobutyl)-N1-{4-[(3-aminopropyl)-amino]-bu-
tyl}-5-[(3aS,6aR)-5-oxoperhydrocyclopenta[c]thiophen-1-yl] pentana-
mide 4 was successfully obtained as a white solid by column chroma-
tography with solvent C. TLC was performed using pre-coated silica
gel plates (60 mesh, Merck) with £uorescence indicator, and column
chromatography was carried out on silica gel (230^400 mesh, Merck)
with the following systems: (A) CH2Cl2 :MeOH:NH4 OH(20:5:1);
(B) CH2Cl2 :MeOH:NH4OH (70:10:1); (C) CH2Cl2 :MeOH:NH4OH
(4:3:1). Non-radioactive compounds were detected by spraying the
plates with phosphomolybdic acid (10%) in ethanol and heating
them.
2.2. Puri¢cation of human TGase 2
TGase 2 was puri¢ed from human red blood cells (RBCs) as pre-
viously described [17]. Human RBCs were lysed by osmotic pressure
in distilled water, centrifuged and the supernatants were collected.
TGase 2 was puri¢ed from these crude extracts by sequential column
chromatography steps using DEAE-cellulose and a heparin column.
Puri¢cation pro¢les were obtained from the protein quantitation and
enzyme activity assays. Purity was evaluated by 12% SDS^PAGE and
by Coomassie staining. Puri¢ed TGase 2 was stored in storage bu¡er
(50 mM Tris^HCl, pH 8.0, 1 mM EDTA, 5 mM 2-mercaptoethanol,
150 mM NaCl, 50% glycerol, 2 Wg/ml phenylmethylsulfonyl £uoride,
2 Wg/ml leupeptin, 2 Wg/ml pepstatin A, 2 Wg/ml trypsin inhibitor) at
370‡C.
2.3. Establishment of stable cell line that expresses TGase 2
293 cells were plated at 5U105 cells per 60-mm dish in Dulbecco’s
modi¢ed Eagle’s medium containing 10% fetal bovine serum). After
16 h of incubation in a humidi¢ed atmosphere with 5% CO2 at 37‡C,
cells were transfected with 2 Wg of full length cDNA of human TGase
2 in pcDNA3 (Invitrogen), or empty vectors, using Lipofectamine
(Invitrogen). Forty-eight hours after transfection, cells were split
and subjected to geneticin (Invitrogen) selection (400 Wg/ml) for 3
weeks. Geneticin-resistant clones derived from single cells were iso-
lated and grown up for further analysis. To test stable expression of
TGase 2, pcDNA3(TGase 2) and empty vector-transfected clones
(2U106 cells) were lysed in 500 Wl of lysis bu¡er (50 mM Tris^HCl,
pH 7.5, 0.5% NP-40, 1 mM EDTA, 1 mM dithiothreitol (DTT), 150
mM NaCl, 2 Wg/ml phenylmethylsulfonyl £uoride, 2 Wg/ml pepstatin,
2 Wg/ml leupeptin, 2 Wg/ml pepstatin A, 2 Wg/ml trypsin inhibitor).
Protein quantitation was performed using the BCA protein assay kit
(Pierce). The expression and enzyme activity of TGase 2 were con-
¢rmed by Western blotting and transamidation assay using anti-hu-
man TGase 2 antibody and [14C]putrescine, respectively.
2.4. Transamidation assay
Transamidation activity was determined by measuring the incorpo-
ration of [14C]putrescine into N,NP-dimethylcasein as previously de-
scribed [14]. In brief, 100^200 Wg of total cell lysates from TGase 2-
overexpressing and control cell lines were incubated with 1 mg of
N,NP-dimethylcasein and 500 nCi of [14C]putrescine (NEN) in reac-
tion bu¡er (50 mM Tris-acetate, pH 7.5, 10 mM CaCl2, 5 mM DTT,
150 mM NaCl, 0.5% Triton X-100, 2 Wg/ml phenylmethylsulfonyl
£uoride, 2 Wg/ml leupeptin, 2 Wg/ml pepstatin A, 2 Wg/ml trypsin in-
hibitor). After 1 h of incubation at 37‡C, the reaction was stopped by
the addition of 7.5% trichloroacetic acid. Radioactivity bound to
N,NP-dimethylcasein was measured by liquid scintillation counting.
Background radioactivity was evaluated with bovine serum albumin
(BSA), a negative control, as an acceptor protein.
2.5. Well plate transamidation assay
Well plate format assay for the measurement of transamidation
activity was performed as previously described [18] with the following
modi¢cations. 50 Wl of N,NP-dimethylcasein (0.1 mg/ml, Sigma) in
coating bu¡er (50 mM Tris^HCl, pH 7.5, 150 mM NaCl, 5 mM
EGTA, 5 mM EDTA) was coated to each well of a 96-well microtiter
(Nunc), and the plate was incubated for 2 h at 37‡C, followed by three
washes with 0.1% Tween 20 in phosphate-bu¡ered saline (PBS). After
subsequent incubation with 200 Wl of 5% BSA in PBS for 2 h at 37‡C,
the wells were washed three times with 0.1% Tween 20 in PBS. Puri-
¢ed human TGase 2 and indicated amounts of BP (Pierce) or BS in 50
Wl of reaction bu¡er (50 mM Tris-acetate, pH 7.5, 10 mM CaCl2,
5 mM DTT, 150 mM NaCl, 0.5% Triton X-100, 0.5 mM EDTA,
pH 8.0) were added to each well, and further incubated for 1 h at
37‡C. Incorporated BP or BS was probed using 1:2500 diluted horse-
radish peroxidase (HRP)-conjugated streptavidin (Jackson Laborato-
ry). The coloring reaction was performed with 50 Wl of substrate so-
lution (0.4 mg/ml of O-phenylenediamine dihydrochloride in 50 mM
sodium citrate phosphate, pH 5.0). The reaction was stopped by the
addition of 1 M H2SO4 and quantitated by measuring the absorbance
at 490 nm on a microplate spectrophotometer (Molecular Devices).
2.6. In situ transamidation assay
The measurement of in situ TGase 2 activity was performed as
previously described [13] with the following modi¢cations. The 293
cell line overexpressing TGase 2 and control cells (2U106) were
treated with 1 mM of BP or BS for 1 h with indicated concentrations
of calcium. Each cell lysate was prepared and dialyzed against coating
bu¡er. 10 Wg of cell lysates was coated and incorporated biotin was
probed as the procedures described for the well plate transamidation
assay. To visualize the BP- or BS-incorporated proteins, 20 Wg of cell
lysates were subjected to 12% SDS^PAGE and transferred to nitro-
cellulose membranes. After blocking and probing with 1:2000 diluted
HRP-conjugated streptavidin, the blots were developed by use of a
standard ECL protocol (Pierce). To compare transport into cells of
BP and BS, 293 cells were plated at 1U104 cells in 96-well plates.
About 16 h later, cells were treated with 1 mM of BP or BS for the
indicated times. After washing with PBS twice, ethanol ¢xation was
performed and the cells were allowed to dry in the air. Then, cells
were treated with 0.25% glutaraldehyde (ICN) in PBS at room tem-
perature for 15 min, followed by 0.5% sodium borohydride (Sigma) at
room temperature for 10 min. After a subsequent incubation with 200
Wl of 5% BSA in PBS at room temperature for 2 h, transported BP or
BS was probed using HRP-conjugated streptavidin and chromogenic
substrate o-phenylenediamine dihydrochloride (Sigma). Assays were
quantitated by measuring the absorbance at 490 nm on a microplate
spectrophotometer (Molecular Devices). In parallel, to visualize trans-
ported BP or BS, immunocytochemical staining was performed using
Texas red-conjugated streptavidin (Jackson Laboratory).
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3. Results and discussion
3.1. Synthesis of biotinylated spermine
Protection of NH2 groups with ethyl TFA a¡orded com-
pound 2 in a nearly quantitative yield. The diagnostic NMR
signals for compound 2 were observed at 2.44 ppm
(^CH2NHCOCF3) in the 1H NMR spectrum and 157.10
ppm, 156.74 ppm (^CO^) and 117.59 ppm, 114.73 ppm
(^CF3) in the 13C NMR spectrum (DMSO-d6). In this case,
the four protons appear as a singlet at the same chemical
shift. For the amidation step, the reaction of compound 2
with biotin using DCC and HOBt gives the expected amide
3 in moderate yield (52%). Amidation was a critical step,
because only one of the two NH groups has to react with
biotin. Compound 3 showed a triplet at 4.17 ppm and 4.28
ppm corresponding to the ring proton of biotin in the 1H
NMR spectrum (CDCl3). Deprotection of NH2 a¡ects the
chemical shifts of ^CH2NH2 in the 1H and 13C NMR spectra
of compound 4 (DMSO-d6). In addition, the signals corre-
sponding to ^CH2NH2 are shifted down¢eld to 2.74 ppm
and 55.48 ppm, in comparison with the same signal in com-
pound 3 (2.32 ppm and 41.03 ppm), due to the L e¡ect.
3.2. In vitro transamidation of biotinylated spermine
One or both of the primary amino groups of polyamines
serve as natural acyl acceptor substrates for TGase [15]. In
contrast to the limited substrate speci¢city of the acyl donor,
the Q-carboxamide group of peptide-bound glutamine resi-
dues, TGases display broad speci¢city for acceptor substrates
[1]. Although determination of [14C]putrescine or BP incorpo-
ration has been used for in vitro TGase activity assay,
[14C]putrescine, when added to cultured cells, is converted
into spermidine or spermine for the formation of protein^
polyamine conjugates [19]. Moreover, the intracellular con-
centration of putrescine was much lower than that of spermi-
dine or spermine in eukaryotic cells (V1%) [20]. Thus, we
chose spermine for synthesizing the biotinylated derivative,
and compared the acyl acceptor substrate speci¢city between
BP and BS. Incorporation of BP or BS into N,NP-dimethylca-
sein by puri¢ed TGase 2 was measured using the well plate
transamidation assay method. As shown in Fig. 2, BP showed
signi¢cantly higher incorporation than BS when the substrate
concentration was below 2 mM, and calculated Km values are
0.01 mM and 0.09 mM, respectively. These results indicate
that BP has a higher a⁄nity for TGase 2 than BS, and could
be used as a better acyl acceptor substrate for in vitro TGase
2 assays.
3.3. In situ transamidation of biotinylated spermine
It had been demonstrated that exogenous radiolabeled
polyamines, when incubated with mitogen-stimulated lympho-
cytes [15] or partially hepatectomized rat liver [21], were in-
corporated into cellular proteins at di¡erent rates. To com-
pare the incorporation between two substrates in situ, we
generated a TGase 2-overexpressing cell line, using 293 cells
that have no detectable expression of TGase 2. Overexpres-
sion of TGase 2 was identi¢ed by Western blotting using anti-
TGase 2 antibody (Fig. 3A, upper), and further con¢rmed by
the measurement of incorporated [14C]putrescine into N,NP-
dimethylcasein. Cell lysates of the TGase 2-overexpressing cell
line showed a more than 30-fold increase in transamidation
activity compared to the control cell line (Fig. 3A). Next, we
compared in situ TGase 2 activity using BP and BS. In con-
trast to in vitro activity of TGase 2, in situ activity was not
detected in either cell line (Fig. 3B,C). Under physiological
conditions, the concentration of intracellular free calcium
ions (V1037 M) is not su⁄cient to activate TGase 2. There-
fore, we added calcium to the culture media and adjusted the
¢nal concentration to 5 mM or 10 mM. Cell viability was not
a¡ected at these calcium concentrations (data not shown). In
situ activity of TGase 2 assayed with BP showed a more than
10-fold increase in high calcium concentration (Fig. 3B). But
when assayed with BS, in situ TGase 2 activity was increased
slightly (Fig. 3C), thus resulting in a di¡erential incorporation
between BP and BS. We con¢rmed this result by visualizing
the proteins conjugated with BP or BS with streptavidin-HRP.
Proteins conjugated with BP were increased in TGase 2-over-
expressing as well as control cells at the high calcium condi-
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Fig. 1. Synthesis scheme of biotinylated spermine. i, CF3COOEt,
THF, 0‡C, 10 min; ii, biotin, DCC, HOBt, DMF, rt 24 h; iii, 2 M
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Fig. 2. Comparison of substrate speci¢city between BP and BS in
vitro. A: Schematic presentation of BP (left) and BS (right). B: In-
corporation of BP or BS into N,NP-dimethylcasein by TGase 2.
Transamidation activity was measured using the well plate transami-
dation assay. Substrate concentrations were 0.0078, 0.0316, 0.125,
0.5, and 2 mM. Incorporated BP and BS were determined using
HRP-conjugated streptavidin and o-phenylenediamine dihydrochlor-
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pendent experiments.
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Fig. 3. Comparison of in situ transamidation activity using BP and BS as amine substrates in TGase 2-overexpressing 293 cells. A: Establish-
ment of TGase 2-overexpressing cell line. Full length of TGase 2 cloned in pcDNA3 or empty vector was transfected into 293 cells. Geneticin-
resistant clones were isolated and grown up for further analysis. Stable expression of TGase 2 was validated by Western blotting using anti-
TGase 2 antibody (upper) and further con¢rmed by the quantitation of [14C]putrescine incorporation (lower). 293 and 293-TG indicate empty
vector-derived control cell line and TGase 2-overexpressing cell line, respectively. B,C: Measurement of incorporated BP (B) and BS (C). 293
and 293-TG cells (2U106) were treated with 1 mM BP or BS in the presence of indicated calcium concentrations for 1 h. Cells were then lysed
by sonication, and 10 Wg of cell lysate was used for in situ transamidation assay. The BP- or BS-incorporated proteins of each cell line were
probed using HRP-conjugated streptavidin. Results are presented as the meanVS.D. of at least three independent experiments. NT, no treat-
ment.
Fig. 4. A: Visualization of incorporated BP or BS. BP- or BS-treated cells in the absence or presence of calcium were lysed by sonication. 20
Wg of each cell lysate was subjected to 12% SDS^PAGE and transferred to nitrocellulose membrane. After blocking and probing with HRP-
conjugated streptavidin, the blots were developed by standard ECL protocol. Arrows indicate endogenous biotin-conjugated proteins. B: Up-
take of BP and BS by 293 cells. 293 cells were incubated with 1 mM of BP or BS for the indicated times. Cells were washed and ¢xed immedi-
ately. After treatment with glutaraldehyde and sodium borohydride at room temperature, transported BP or BS was probed using HRP-conju-
gated streptavidin. NT, no treatment. C: Microscopic visualization of transported BP and BS in 293 cells. BP or BS was probed using Texas
red-conjugated streptavidin.
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tion. By contrast, no protein^BS conjugate was detected even
in TGase 2-overexpressing cells at high calcium concentration
(Fig. 4A).
In order to test whether di¡erential incorporation of bio-
tinylated polyamines results from a di¡erence in polyamine
transport rates, we measured the relative concentrations of
intracellular BP and BS. 293 cells stably expressing TGase 2
were incubated with BP or BS over a period of 20 min. Cells
were then washed, and uptake of polyamine was determined.
However, free BP or BS was not held in the intracellular
location because of their low molecular weight. We thus
used the chemical cross-linking method to quantitate the
free intracellular polyamines. As demonstrated in Fig. 4B,
both BP and BS enter the cell immediately and maintain a
constant level after 15 min. We found no di¡erence in trans-
port between BP and BS. In addition, we further con¢rmed
polyamine uptake by the microscopic visualization of intra-
cellular biotinylated polyamines using immunocytochemistry
(Fig. 4C). Therefore, these results indicate that in situ TGase 2
activity may be assayed di¡erently depending on the sub-
strates supplied.
The presence of polyamine-conjugated or cross-linked pro-
tein is evidence of in situ TGase activity. The reaction rate of
intracellular TGase largely depends on the physiological con-
centration of polyamines. Eukaryotic cells contain polyamines
at abundant levels, but most of the polyamines, which are
positively charged at physiological pH, are sequestered by
interacting non-covalently with negatively charged cellular
components, such as DNA, RNA or phospholipids [22].
Thus, only a small fraction of polyamines, free polyamine,
would be available for TGase-mediated acyl transfer reac-
tions. Most polyamine derivatives, even with large substitu-
ents on the secondary amino group of spermidine and sper-
mine, are taken up by most cells [23]. BP used in this study,
however, could not interact with negatively charged cellular
constituents because one of two primary amino groups is
protected by a biotin residue (Fig. 2A). This suggests a sub-
stantial in vivo accumulation of free BP. By contrast, for BS
biotin was amidated on the secondary amino group of sper-
mine and could be a substrate of spermidine/spermine N1-
acetyltransferase, the rate-limiting enzyme in polyamine ca-
tabolism [24]. Additionally, studies with transgenic mice over-
expressing ornithine decarboxylase, a regulatory enzyme in
polyamine biosynthesis [25], or spermidine/spermine N1-ace-
tyltransferase [20] showed excessive accumulation of putres-
cine but minimal derangement in spermidine and spermine
concentrations, indicating that spermidine and spermine are
more strictly maintained by complex regulatory mechanisms
than putrescine. Previous studies showing that exogenous
spermine might act as a growth inhibitor of prostate cancer
cells [26], and polyamine-induced programmed cell death [27],
further support the importance of spermidine and spermine
regulation on cell viability. Taken together, these observations
suggest that higher in situ incorporation of BP than BS might
be due to di¡erences in free substrate concentrations.
The measurement of physiological activity of TGase 2 is an
essential step to understand its biological function. Enzyme
assays with high sensitivity may lead to overestimation of
the physiological value or false-positives. Thus, the selection
of a suitable method and substrate is one of the keys to ex-
actly represent enzyme activity or function. Although TGase 2
is overexpressed in the cell line used, its activity is dormant
inside the cells. Together, these results show that the expres-
sion level of TGase 2 cannot represent enzymatic activity.
Moreover, our results indicate the possibility of overrepresen-
tation of in situ activity of TGase 2 as a consequence of the
choice of substrates. Therefore, to evaluate the role of TGase
2 in several pathologic situations, careful interpretation of in
situ activity may be required.
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